Alannah M. Smrke

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 04, 2026

2025 Canadian Surgery Forum: Sept. 17-20, 2025.

2025 Canadian Surgery Forum: Sept. 17-20, 2025.

Journal: Canadian journal of surgery. Journal canadien de chirurgie

Published: December 09, 2025

CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021).

CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021).

Journal: Cancer treatment and research communications

Published: September 30, 2025

A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study.

A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study.

Journal: Cancer medicine

Published: September 09, 2025

A multidisciplinary evaluation of fertility preservation for oncology patients in Canada The British Columbia perspective.

A multidisciplinary evaluation of fertility preservation for oncology patients in Canada The British Columbia perspective.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: September 02, 2025

Kaposi sarcoma posthematopoietic stem cell transplant for vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome.

Kaposi sarcoma posthematopoietic stem cell transplant for vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome.

Journal: JAAD case reports

Published: March 24, 2025

Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic Rhabdomyosarcoma.

Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic Rhabdomyosarcoma.

Journal: Genes, chromosomes & cancer

Published: June 28, 2024

Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across Canada.

Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across Canada.

Journal: Therapeutic advances in medical oncology

Published: March 22, 2024

Survival Outcomes of Ewing Sarcoma and Rhabdomyosarcoma by High- versus Low-Volume Cancer Centres in British Columbia, Canada.

Survival Outcomes of Ewing Sarcoma and Rhabdomyosarcoma by High- versus Low-Volume Cancer Centres in British Columbia, Canada.

Journal: Diagnostics (Basel, Switzerland)

Published: March 28, 2023

Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.

Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.

Journal: Cancer medicine

Published: March 21, 2023

The Role of Imaging in the Diagnosis of Primary and Secondary Breast Angiosarcoma: Twenty-Five-Year Experience of a Provincial Cancer Institution.

The Role of Imaging in the Diagnosis of Primary and Secondary Breast Angiosarcoma: Twenty-Five-Year Experience of a Provincial Cancer Institution.

Journal: Clinical breast cancer

Published: June 04, 2022

Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network.

Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network.

Journal: ESMO open

Published: April 21, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026